Simulators help industry design better trials

Share this article:

Computers are helping drug companies design smarter clinical trials. The Wall Street Journal reports that manufacturers, such as Pfizer, are using simulators to troubleshoot trial designs and identify potential shortcomings, such as too few patients, before implementation.

The WSJ says the hope is that these programs can cut down on the number of drugs which fail to get regulatory approval due to trial shortcomings, rather than due to issues with the drugs themselves.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Social media perceived as clinical trial risk

The Wall Street Journal reports that patients are sharing a plethora of information about their clinical trial experiences, from how to get picked, to how to figure out who is in a control group.

Cancer PSA features scientists

Stand Up To Cancer is kicking off a PSA that features Grammy-winner Jennifer Hudson and a Genentech scientist.

Lawmakers eye pricing

The Senate Judiciary Committee's antitrust panel is looking into how three major pharmaceutical manufacturers decided to set minimum prices for their contact lenses.